PMVP

PMV Pharmaceuticals, Inc.

1.88 USD
+0.03 (+1.62%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

PMV Pharmaceuticals, Inc. stock is up 6.82% since 30 days ago. The next earnings date is May 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 3 March’s closed higher than February.

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function.